Press release on USFDA inspection for Singapore facility. Just as a reference - FY22 revenue from US was $157 Mn. This will support company’s outlook to achieve target of $250 Mn. revenue from US for FY23
Subscribe To Our Free Newsletter |
Press release on USFDA inspection for Singapore facility. Just as a reference - FY22 revenue from US was $157 Mn. This will support company’s outlook to achieve target of $250 Mn. revenue from US for FY23
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!